(Q43557302)

24 November 2017

Effect of orlistat-assisted weight loss in decreasing coronary heart disease risk in patients with syndrome X. (English)

1 reference

24 November 2017

1 reference

coronary artery disease

1 reference

Reaven G

1

1 reference

24 November 2017

Segal K

2

1 reference

24 November 2017

Hauptman J

3

1 reference

24 November 2017

Boldrin M

4

1 reference

24 November 2017

Lucas C

5

1 reference

24 November 2017

language of work or name

English

0 references

publication date

1 April 2001

1 reference

American Journal of Cardiology

24 November 2017

1 reference

24 November 2017

87

1 reference

24 November 2017

7

1 reference

24 November 2017

827-831

1 reference

Relationship between degree of obesity and in vivo insulin action in man

24 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Effects of weight reduction on obesity. Studies of lipid and carbohydrate metabolism in normal and hyperlipoproteinemic subjects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Immunoassay of insulin with insulin-antibody precipitate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Banting lecture 1988. Role of insulin resistance in human disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Relationship between resistance to insulin-mediated glucose uptake, urinary uric acid clearance, and plasma uric acid concentration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Relation between insulin resistance, hyperinsulinemia, postheparin plasma lipoprotein lipase activity, and postprandial lipemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Insulin resistance and hyperinsulinemia in individuals with small, dense low density lipoprotein particles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Comparison of plasminogen activator inhibitor-1 concentration in insulin-resistant versus insulin-sensitive healthy women.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Evidence for an independent relationship between insulin resistance and fasting plasma HDL-cholesterol, triglyceride and insulin concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Effect of weight loss on blood pressure and insulin resistance in normotensive and hypertensive obese individuals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Plasma-high-density-lipoprotein concentration and development of ischaemic heart-disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Plasma triglyceride level and mortality from coronary heart disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Why is insulin not a risk factor for coronary heart disease?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Hypertriglyceridemia and elevated lipoprotein(a) are risk factors for major coronary events in middle-aged men

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Hyperinsulinemia as an independent risk factor for ischemic heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Hyperinsulinemia in a normal population as a predictor of non-insulin-dependent diabetes mellitus, hypertension, and coronary heart disease: the Barilla factory revisited.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Low-Density Lipoprotein Subclass Patterns and Risk of Myocardial Infarction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Postchallenge plasma lipoprotein retinoids: chylomicron remnants in endogenous hypertriglyceridemia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients. European Multicentre Orlistat Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2800%2901521-6

10.1016/S0002-9149(00)01521-6

7 January 2021

Identifiers

DOI

1 reference

24 November 2017

1 reference